Hoffbrand's essential haematology
(Other)

Includes bibliographical references and index.

"Advances in the understanding the pathogenesis of blood diseases and improvements in their treatment have continued apace in the five years since the 8th edition of HEH was published. Gene mutations are increasingly used to define and classify inherited and acquired haematological diseases, as a guide to therapy and to predict prognosis. Mutations underlying many rarer blood diseases have been identified, allowing appropriate panels of DNA probes to be established, facilitating the diagnosis of future cases. Many more drugs directed against specific sites in the cell signalling pathways have been approved"-- Provided by publisher.